Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
8
Mins
31 Oct 2024
Remission Without Glucocorticoids as a SLE Treatment Goal
SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately attacks healthy…
31 Oct 2024
Merging Hope and Science in Patient Care
This week Jonathan is joined by Isabelle Amigues. Together, they discuss the first part of her career as an academic clinician followed by how her diagnosis of Stage IV breast cancer shaped her approach to use the best in data-driven Western medicine combined with traditional Eastern healing.
31 Oct 2024
Evolving Strategies in Managing Rheumatoid Arthritis Treatment Choices
The management of rheumatoid arthritis (RA) has significantly evolved, moving beyond the mere application of clinical trial results to a more nuanced approach…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
29 Oct 2024
Autoimmune Diseases Linked to Premature Ovarian Insufficiency Risk
New research has shown that women with premature ovarian insufficiency (POI) have more than double the prevalence of severe autoimmune diseases compared to the general female population.
27 Oct 2024
The Surprising Impact of Hot Temperatures on Raynaud’s Disease
The severity of Raynaud’s disease is not only linked to very low temperatures, but also hot environments that reach 35°C and above, according to recent research.
25 Oct 2024
Frailty Predicts Severe Infections in Older Adults with Vasculitis
New research has demonstrated that frailty, a measure of biological age, predicts severe infections in older adults with incident antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
24 Oct 2024
Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases
In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital
Loading posts...
« Previous
1
…
25
26
27
28
29
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View